Detection of nonhemagglutinating influenza A(H3) viruses by enzyme-linked immunosorbent assay in quantitative influenza virus culture

Journal of Clinical Microbiology

Volumn 52, Issue 5, 2014, Pages 1672-1677

  Van Baalen, C A ^a   Els, C ^a   Sprong, L ^a   Van Beek, R ^b   Van Der Vries, E ^b   Osterhaus, A D M E ^a,b   Rimmelzwaan, G F ^a,b  

^a Viroclinics Biosciences BV   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; VIRUS NUCLEOPROTEIN; ANTIVIRUS AGENT; CORE PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; INFLUENZA A (H3); INFLUENZA A (H3N2); INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; TISSUE CULTURE; VALIDITY; VIRUS CULTURE; VIRUS DETECTION; VIRUS HEMAGGLUTINATION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION; ANIMAL; CELL LINE; CHEMISTRY; CLINICAL TRIAL; DOG; DOG DISEASES; DRUG EFFECTS; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MDCK CELL LINE; NETHERLANDS; ORTHOMYXOVIRIDAE INFECTIONS; PROCEDURES; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MADIN DARBY CANINE KIDNEY CELLS; NETHERLANDS; ORTHOMYXOVIRIDAE INFECTIONS; VIRAL CORE PROTEINS;

EID: 84899584673     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03575-13     Document Type: Article

References (26)

1. Asaoka N, Tanaka Y, Sakai T, Fujii Y, Ohuchi R, Ohuchi M. 2006. Low growth ability of recent influenza clinical isolates in MDCK cells is due to their low receptor binding affinities. Microbes Infect. 8:511-519. http://dx.doi.org/10.1016/j.micinf.2005.08.006.
2. Lin YP, Xiong X, Wharton SA, Martin SR, Coombs PJ, Vachieri SG, Christodoulou E, Walker PA, Liu J, Skehel JJ, Gamblin SJ, Hay AJ, Daniels RS, McCauley JW. 2012. Evolution of the receptor binding properties of the influenza A (H3N2) hemagglutinin. Proc. Natl. Acad. Sci. U. S. A. 109:21474-21479. http://dx.doi.org/10.1073/pnas.1218841110.
3. Gulati S, Smith DF, Cummings RD, Couch RB, Griesemer SB, St. George K, Webster RG, Air GM. 2013. Human H3N2 influenza viruses isolated from 1968 to2012 show varying preference for receptor substructures with no apparent consequences for disease or spread. PLoS One 8:e66325. http://dx.doi.org/10. 1371/journal.pone.0066325.
4. Kumari K, Gulati S, Smith DF, Gulati U, Cummings RD, Air GM. 2007. Receptor binding specificity of recent human H3N2 influenza viruses. Virol. J. 4:42. http://dx.doi.org/10.1186/1743-422X-4-42.
5. Medeiros R, Escriou N, Naffakh N, Manuguerra JC, van der Werf S. 2001. Hemagglutinin residues of recent human A (H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Virology 289:74-85. http://dx.doi.org/10.1006/viro.2001.1121.
6. Nobusawa E, Ishihara H, Morishita T, Sato K, Nakajima K. 2000. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology 278:587-596. http://dx.doi.org/10.1006/viro. 2000.0679.
7. Oh DY, Barr IG, Mosse JA, Laurie KL. 2008. MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells. J. Clin. Microbiol. 46:2189-2194. http://dx.doi.org/10.1128/JCM. 00398-08.
8. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, Fukuda K, Cox NJ, Katz JM. 1999. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 37:937-943.
9. WHO. 2011. Manual for the laboratory diagnosis and virological surveillance of influenza. WHO Press, Geneva, Switzerland. http://whqlibdoc.who. int/publications/2011/9789241548090-eng.pdf.
10. Rimmelzwaan GF, Baars M, Claas EC, Osterhaus AD. 1998. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescenceas methods for monitoring influenza virus replication in vitro. J. Virol. Methods 74:5766.
11. van der Vries E, Anber J, van der Linden A, Wu Y, Maaskant J, Stadhouders R, van Beek R, Rimmelzwaan G, Osterhaus A, Boucher C, Schutten M. 2013. Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations. J. Mol. Diagn. 15:347-354. http://dx.doi.org/10.1016/j.jmoldx.2012.11.007.
12. Kärber G. 1931. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch. Exp. Pathol. Pharmakol. 162:480-483. (Article in German.) http://dx.doi.org/10.1007/BF01863914.
13. de Boer GF, Back W, Osterhaus AD. 1990. An ELISA for detection of antibodies against influenza A nucleoprotein in humans and various animal species. Arch. Virol. 115:47-61. http://dx.doi.org/10.1007/BF01310622.
14. Nicholls JM, Wong LP, Chan RW, Poon LL, So LK, Yen HL, Fung K, van Poucke S, Peiris JS. 2012. Detection of highly pathogenic influenza and pandemic influenza virus in formalin fixed tissues by immunohistochemical methods. J. Virol. Methods 179:409-413. http://dx.doi.org/10.1016/j.jviromet.2011.11.006.
15. Barr IG, McCauley J, Cox N, Daniels R, Engelhardt OG, Fukuda K, Grohmann G, Hay A, Kelso A, Klimov A, Odagiri T, Smith D, Russell C, Tashiro M, Webby R, Wood J, Ye Z, Zhang W, Writing Committee of the World Health Organization Consultation on Northern Hemisphere Influenza Vaccine Composition for 2009-2010. 2010. Epidemiological, antigenic and genetic characteristics of seasonal influenza A (H1N1), A (H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine 28:1156-1167. http://dx.doi.org/10.1016/j. vaccine.2009.11.043.
16. Katz JM, Hancock K, Xu X. 2011. Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev. Anti. Infect. Ther. 9:669-683. http://dx.doi.org/10.1586/eri.11.51.
17. Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G, Skepner E, Lewis NS, Spronken MI, Russell CA, Eropkin MY, Hurt AC, Barr IG, de Jong JC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Smith DJ. 2013. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342:976-979. http://dx.doi.org/10. 1126/science.1244730.
18. Li Y, Bostick DL, Sullivan CB, Myers JL, Griesemer SB, St. George K, Plotkin JB, Hensley SE. 2013. Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering. J. Virol. 87:9904-9910. http://dx.doi.org/10.1128/JVI.01023-13.
19. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376. http://dx.doi.org/10.1126/science.1097211.
20. Yewdell JW, Frank E, Gerhard W. 1981. Expression of influenza A virus internal antigens on the surface of infected P815 cells. J. Immunol. 126:1814-1819.
21. Kreijtz JH, Veldhuis Kroeze EJ, Stittelaar KJ, de Waal L, van Amerongen G, van Trierum S, van Run P, Bestebroer T, Kuiken T, Fouchier RAM, Rimmelzwaan GF, Osterhaus AD. 2013. Low pathogenic avian influenza A (H7N9) virus causes high mortality in ferrets upon intratracheal challenge: a model to study intervention strategies. Vaccine 31:4995-4999. http://dx.doi.org/10.1016/j. vaccine.2013.06.071.
22. Okuno Y, Tanaka K, Baba K, Maeda A, Kunita N, Ueda S. 1990. Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system. J. Clin. Microbiol. 28:1308-1313.
23. Rota PA, Hemphill ML, Whistler T, Regnery HL, Kendal AP. 1992. Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus. J. Gen. Virol. 73:2737-2742. http://dx.doi.org/10. 1099/0022-1317-73-10-2737.
24. Veguilla V, Hancock K, Schiffer J, Gargiullo P, Lu X, Aranio D, Branch A, Dong L, Holiday C, Liu F, Steward-Clark E, Sun H, Tsang B, Wang D, Whaley M, Bai Y, Cronin L, Browning P, Dababneh H, Noland H, Thomas L, Foster L, Quinn CP, Soroka SD, Katz JM. 2011. Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U. S. populations. J. Clin. Microbiol. 49:2210-2215. http://dx.doi.org/10.1128/JCM.00229-11.
25. Cox RJ, Madhun AS, Hauge S, Sjursen H, Major D, Kuhne M, Höschler K, Saville M, Vogel FR, Barclay W, Donatelli I, Zambon M, Wood J, Haaheim LR. 2009. A phase I clinical trial of a PER. C6 cell grown influenza H7 virus vaccine. Vaccine 27:1889-1897. http://dx.doi.org/10.1016/j.vaccine.2009.01.116.
26. Keitel WA, Atmar RL. 2009. Vaccines for pandemic influenza: summary of recent clinical trials. Curr. Top. Microbiol. Immunol. 333:431-451. http://dx.doi.org/10.1007/978-3-540-92165-3-21.